[1] Rosenblatt J, Kufe D, Avigan D. Dendritic cell fusion vaccines for cancer immunotherapy [J]. Expert Opin Biol Ther, 2005, 5 (5):703-15. [2] Hayashi T, Nakao K, Nagayama Y, et al. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models[J]. Int J Oncol, 2005, 26(5): 1313-9. [3] Okano F, Merad M, Furumoto K, et al. In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity [J]. J Immunol, 2005, 174(5): 2645-52. [4] 尤长宣,罗荣城,苏瑾,等.腺相关病毒介导乳腺癌BA46基因转移的实验研究[J].中华微生物与免疫学杂志,2004,24(9):724-7.You CX, Luo RC, Su J, et al. Adeno-associated virus mediate the breast cancer BA46 gene transfer into dendritic cells [J]. Chin J Microbiol Immunol, 2004, 24(9): 724-7. [5] Liu Y, You CX, Luo RC, et al. Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinated virus-based gene loading of dendritic cells[J]. Cancer Gene Ther, 2004, 12(1): 1-9. [6] Zitvoge IL, Mayordomo J, Tjandrawan T, et al. Therapy of murine tumors with tumor peptide pulsed dendritic cells: dependence on T cells, B7 co-stimulation, and T help cell 1 associated cytokines[J]. J Exp Med, 1996, 183(1): 87-97. [7] Nakamura I, Kajino K, Bamba H, et al. Phenotypic stability of mature dendritic cells tuned by TLR or CD40 to control the efficiency of cytotoxic T cell priming [J]. Microbiol Immunol, 2004, 48 (3):211-9. [8] Colombo MP, Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy [J]. Cytokine Growth Factor Rev, 2002, 13(1):155-68. [9] Heystek HC, Mudde GC, Ohler R, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) has opposing effects on the capacity of monocytes versus monocyte-derived dendritic cells to stimulate the antigen-specific proliferation of a human T cell clone [J]. Clin Exp Immunol, 2000, 120(3): 440-7. [10] Lutz MB, Schnare M, Menges M, et al. Differential functions of IL-4 receptor types Ⅰ and Ⅱ for dendritic cell maturation and IL-12 production and their dependency on GM-CSF [J]. J Immunol, 2002,169(7): 3574-80. [11] Wan Y, Lu L, Bramson JL, et al. Dendritic cell-derived IL-12 is not required for the generation of cytotoxic, IFN-gamma-secreting, CD8 (+) CTL in vivo[J]. J Immunol, 2001, 167(9): 5027-33. [12] Yang S, Vervaert CE, Burch J Jr, et al. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8 (+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity [J]. Int J Cancer, 1999, 83(4):532-40. |